Enveric Biosciences Inc (ENVB) — Capital Reinvestment Ratio

Latest as of June 2018: 0.08x

Enveric Biosciences Inc (ENVB) has a Capital Reinvestment Ratio of 0.08x as of June 2018, meaning it reinvests 0% of its operating cash flow ($180.21K) in capital expenditures ($13.88K). Check how tangible is Enveric Biosciences Inc's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

$180.21K
USD

Capital Expenditures

$13.88K
USD

Data as of

Jun 2018
Most recent filing

Enveric Biosciences Inc Capital Reinvestment Ratio (2000–2004)

This chart tracks Enveric Biosciences Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Enveric Biosciences Inc (ENVB) cash conversion ratio.

Annual Capital Reinvestment Ratio for Enveric Biosciences Inc (2000–2004)

Year-by-year Capital Reinvestment Ratio for Enveric Biosciences Inc from 2000 to 2004. See ENVB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2004 0.01x $343.94K $4.01K ▼ -98.7%
2002 0.88x $85.14K $74.99K ▲ +217.3%
2000 0.28x $145.84K $40.49K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow